Pectins from various sources inhibit galectin-3-related cardiac fibrosis-Reference-Cited by-同舟云学术

Pectins from various sources inhibit galectin-3-related cardiac fibrosis

Published:2022-01 Issue:1 Volume:70 Page:103321
ISSN:2452-3186
Container-title:Current Research in Translational Medicine
language:en
Short-container-title:Current Research in Translational Medicine

Author:

Pozder geb. Gehlken Carolin^ORCID,Rogier van der Velde A.,Meijers Wouter C.,Silljé Herman H.W.,Muntendam Pieter,Dokter Martin M.,van Gilst Wiek H.^ORCID,Schols Henk A.,de Boer Rudolf A.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference54 articles.

1. Global Public health burden of heart failure;Savarese;Card Fail Rev,2017

2. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology;de Boer;Eur J Heart Fail [Internet],2019

3. Myofibroblast-mediated mechanisms of pathological remodelling of the heart;Weber;Nat Rev Cardiol,2013

4. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy;Gulati;JAMA,2013

5. The pathogenesis of cardiac fibrosis;Kong;Cell Mol Life Sci,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma proteins associated with plant-based diets: Results from the Atherosclerosis Risk in Communities (ARIC) study and Framingham Heart Study (FHS);Clinical Nutrition;2024-08

2. Pectin: Health-promoting properties as a natural galectin-3 inhibitor;Glycoconjugate Journal;2024-04

3. Toxicological evaluation of a pumpkin-derived pectin preparation: in vitro genotoxicity studies and a 13-week oral toxicity study in Sprague-Dawley rats;Toxicology Research;2024-01-01

4. Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents;Pharmaceuticals;2023-10-12

5. Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis;Nature Communications;2023-08-31